HR 4030 United States House · 119th Congress

Treatment Continuity Act of 2025

This bill updates federal grant programs to expand access to long-acting injectable medications, lab testing, and counseling for people with substance use disorders or serious mental illness. It requires grant recipients (state/local health agencies) to provide these specific services and train clinicians on medication use. The changes apply to new grants starting after the bill's enactment. Annual reports on program outcomes must also be submitted to Congress.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
President
Introduced Jun 17, 2025 Last action Jun 17, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jun 17, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 17, 2025
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors

Sponsors